Detection of aberrant methylation of tumor suppressor genes in plasma from cancer patients
- 4 May 2013
- journal article
- Published by International Society of Personalized Medicine in Personalized Medicine Universe
- Vol. 2, 20-24
Abstract
Purpose: For personalized medicine, a novel biomarker is necessary for screening and monitoring of cancer. DNA methylation of the promoter region of tumor suppressor gene(s) has been detected in tumor tissue and plasma/serum from patients with various types of cancer. To investigate the methylation status of gene promoters in plasma from cancer patients, we examined the frequency of methylation in the promoter regions of the APC, DCC, p16INK4a, p14ARF, and RASSF1A genes in plasma. Methods: Samples of plasma were obtained from 244 patients with colon cancer, lung cancer, pancreatic cancer, gastric cancer, hepatocellular carcinoma, and breast cancer. Cell-free DNA was extracted from each plasma sample and the methylation status of the promoters of the APC, DCC, p16INK4a, p14ARF, and RASSF1A genes were examined by methylation-specific PCR. Results: Methylation of the promoter of the APC and RASSF1A genes was detected in plasma from patients with each type of cancer. Notably, methylation of the APC and RASSF1A promoters was detected in plasma from patients with HCC at a high frequency. However, the frequency of methylation of the promoters of the DCC and p14ARF genes from patients with HCC was lower than that of patients with colon cancer. Conclusion: Our results indicate that the frequency of methylation of cancer-related genes is dependent on the type of cancer and patient. Therefore, DNA methylation of cancer-related genes has a high potential as a biomarker for personalized medicine.Keywords
This publication has 50 references indexed in Scilit:
- Detection of Promoter Hypermethylation in Salivary Rinses as a Biomarker for Head and Neck Squamous Cell Carcinoma SurveillanceClinical Cancer Research, 2011
- Personalized medicine: new genomics, old lessonsHuman Genetics, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancerArchives of Medical Science, 2011
- DNA methylation predicts recurrence from resected stage III proximal colon cancerCancer, 2010
- Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast CancerClinical Cancer Research, 2008
- Dynamics of RASSF1A/MOAP-1 Association with Death ReceptorsMolecular and Cellular Biology, 2008
- The Epigenomics of CancerCell, 2007
- Colorectal cancer: genetics of development and metastasisJournal of Gastroenterology, 2006
- Cancer genes and the pathways they controlNature Medicine, 2004